Prenetics Global Limited (NASDAQ:PRENW – Get Free Report) was the recipient of a large increase in short interest in February. As of February 27th, there was short interest totaling 14,634 shares, an increase of 741.0% from the February 12th total of 1,740 shares. Based on an average daily volume of 14,529 shares, the days-to-cover ratio is currently 1.0 days. Based on an average daily volume of 14,529 shares, the days-to-cover ratio is currently 1.0 days.
Prenetics Global Price Performance
Shares of PRENW traded down $0.00 during midday trading on Tuesday, hitting $0.02. The company had a trading volume of 39,260 shares, compared to its average volume of 19,729. The company’s 50 day moving average price is $0.02 and its 200 day moving average price is $0.03. Prenetics Global has a 52 week low of $0.01 and a 52 week high of $0.07.
Prenetics Global Company Profile
Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.
Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.
Further Reading
- Five stocks we like better than Prenetics Global
- Gold’s Next Surge is Imminent
- “I just bought 10,000 shares of a $5 stock…”
- Have $500? Invest in Elon’s AI Masterplan
- What a Former CIA Agent Knows About the Coming Collapse
- The gold chart Wall Street is terrified of…
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
